Family Dollar has promoted Bonita Price to Chief Merchant. According to an announcement on the company's LinkedIn, Bonita will be responsible for the strategic direction of Family Dollar Merchandising, Merchandising Operations, and Marketing in her expanded role.
Most recently, Bonita served as the Senior Vice President of Discretionary for Family Dollar. Her career in value retailing spans over 25 years and includes executive positions at Payless Shoe Source, Ashley Stewart, and TJX.
Bonita Price promoted to Chief Merchant for Family Dollar
Price's career in value retailing spans over 25 years.
Related
FMI issues statement on August 2026 CPI Food Price numbers
“The August CPI numbers bring some modest relief for grocery shoppers,” FMI said.
Kroger posts higher Q2 sales, EPS growth
Kroger reported stronger e-commerce profitability, growth in its retail media business, favorable pharmacy performance, sourcing initiatives, tariff refunds and a lower LIFO inventory charge.
Dollar General Foundation awards $4.1 Million for youth literacy
“When students have access to books, technology and educational resources, they gain tools that can support their learning for years to come.”
Consumers’ return preferences are changing the way Americans shop online
New research from Loop shows that return policies are increasingly deciding where Americans shop, while fraud and abuse add to the pressure on retailers.
Latest
Sanofi and USA Pickleball launch COVID-19 education campaign
Despite their risk of serious illness from COVID-19, nearly 70% of adults 65 and older remain unvaccinated, in part due to concerns about potential side effects
AAM: Generics and biosimilars saved U.S. health system $496 billion in 2025
Generics and biosimilars represented 89% of U.S. prescriptions but only 12% of prescription drug spending in 2025, according to AAM.
FMI issues statement on August 2026 CPI Food Price numbers
“The August CPI numbers bring some modest relief for grocery shoppers,” FMI said.
Study links mRNA flu vaccine to sustained immune response
Researchers found an mRNA flu vaccine produces broader antibodies than conventional ones, offering clues for more lasting influenza protection.